APO RESEARCH · REPORT
Neurorehabilitation
Neurorehabilitation refers to a structured, multidisciplinary set of medical and therapy interventions that aim to restore, compensate for, or optimize neurological function and participation after injury or disease of the central or peripheral nervous system.
Product & engineering
Understand the product.
The research object may be an ingredient, device, preparation or care service. These supply stages have different specifications and measurement units; an ingredient identity or device name does not establish a clinical outcome.
What turns activity into demand
Qualified use at the specified treatment or instrument boundary creates purchases through protocol, utilisation and replacement. A product, clinical service and complete care episode measure different supplied objects.
The commercial boundary
For Neurorehabilitation, distinguish the supplied service or configured system from its inputs and the complete application. Report types and applications may overlap; retain the selected edition's product definition, geography, period, unit and transaction basis when comparing estimates.
Which conditions determine usable neurorehabilitation performance?
Neurorehabilitation refers to a structured, multidisciplinary set of medical and therapy interventions that aim to restore, compensate for, or optimize neurological function and participation after injury or disease of the central or peripheral nervous system. Confirm the specified composition or device function, intended use and supplied unit. Separate ingredients, finished preparations, equipment and treatment activity before comparing quantities or revenue; use the report scope rather than inferring efficacy from an illustration.
Selected research
Industry Growth & Trends
Global Neurorehabilitation Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Neurorehabilitation market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Neurorehabilitation is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Neurorehabilitation is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Neurorehabilitation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Neurorehabilitation market include VISHEE, Beijing Bo'ai Hospital, Beijing Rehabilitation Hospital of Capital Medical University, NCC, CHIEFTAIN, Tongji Hospital, Haobro Medical Device, DIH and Sun Java, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Neurorehabilitation market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Neurorehabilitation market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Neurorehabilitation market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Neurorehabilitation.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Neurorehabilitation market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Neurorehabilitation Market by Company
VISHEE
Beijing Bo'ai Hospital
Beijing Rehabilitation Hospital of Capital Medical University
NCC
CHIEFTAIN
Tongji Hospital
Haobro Medical Device
DIH
Sun Java
Aoyang Health
PKUCare Rehabilitation Hospital
Beijing Puhua International Hospital
Xiangyu Medical
Beijing United Family Rehabilitation Hospital
Neurorehabilitation Segment by Type
Brain Injury
Spinal Cord Injury
Peripheral Nerve Injury
Other
Neurorehabilitation Segment by Application
General Hospital
Rehabilitation Specialist Hospital
Community Rehabilitation Center
Neurorehabilitation Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neurorehabilitation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Neurorehabilitation and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neurorehabilitation.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Neurorehabilitation companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Brain Injury
- Spinal Cord Injury
- Peripheral Nerve Injury
- Other
Applications
- General Hospital
- Rehabilitation Specialist Hospital
- Community Rehabilitation Center
Companies covered
- VISHEE
- Beijing Bo'ai Hospital
- Beijing Rehabilitation Hospital of Capital Medical University
- NCC
- CHIEFTAIN
- Tongji Hospital
- Haobro Medical Device
- DIH
- Sun Java
- Aoyang Health
- PKUCare Rehabilitation Hospital
- Beijing Puhua International Hospital
- Xiangyu Medical
- Beijing United Family Rehabilitation Hospital
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Neurorehabilitation Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Neurorehabilitation Market Size by Region (2021-2032)
- 1.4.1 Global Neurorehabilitation Market Size by Region (2021-2026)
- 1.4.2 Global Neurorehabilitation Market Size by Region (2027-2032)
- 1.5 Key Regions Neurorehabilitation Market Size (2021-2032)
- 1.5.1 North America Neurorehabilitation Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Neurorehabilitation Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Neurorehabilitation Market Size Growth Rate (2021-2032)
- 1.5.4 South America Neurorehabilitation Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Neurorehabilitation Market Size Growth Rate (2021-2032)
2 Neurorehabilitation Market by Type
- 2.1 Type Introduction
- 2.1.1 Brain Injury
- 2.1.2 Spinal Cord Injury
- 2.1.3 Peripheral Nerve Injury
- 2.1.4 Other
- 2.2 Global Neurorehabilitation Market Size by Type
- 2.2.1 Global Neurorehabilitation Market Size Overview by Type (2021-2032)
- 2.2.2 Global Neurorehabilitation Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Neurorehabilitation Market Size Forecasted by Type (2027-2032)
- 2.3 Global Neurorehabilitation Market Size by Regions
- 2.3.1 North America Neurorehabilitation Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Neurorehabilitation Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Neurorehabilitation Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Neurorehabilitation Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Neurorehabilitation Market Size Breakdown by Type (2021-2026)
3 Neurorehabilitation Market by Application
- 3.1 Type Introduction
- 3.1.1 General Hospital
- 3.1.2 Rehabilitation Specialist Hospital
- 3.1.3 Community Rehabilitation Center
- 3.2 Global Neurorehabilitation Market Size by Application
- 3.2.1 Global Neurorehabilitation Market Size Overview by Application (2021-2032)
- 3.2.2 Global Neurorehabilitation Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Neurorehabilitation Market Size Forecasted by Application (2027-2032)
- 3.3 Global Neurorehabilitation Market Size by Regions
- 3.3.1 North America Neurorehabilitation Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Neurorehabilitation Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Neurorehabilitation Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Neurorehabilitation Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Neurorehabilitation Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Neurorehabilitation Industry Trends
- 4.2 Neurorehabilitation Industry Drivers
- 4.3 Neurorehabilitation Industry Opportunities and Challenges
- 4.4 Neurorehabilitation Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Neurorehabilitation Revenue (2021-2026)
- 5.2 Global Neurorehabilitation Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Neurorehabilitation Key Company Headquarters & Area Served
- 5.4 Global Neurorehabilitation Company, Product Type & Application
- 5.5 Global Neurorehabilitation Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Neurorehabilitation Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Neurorehabilitation Players Market Share by Revenue in 2025
- 5.6.3 2025 Neurorehabilitation Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 VISHEE
- 6.1.1 VISHEE Company Information
- 6.1.2 VISHEE Business Overview
- 6.1.3 VISHEE Neurorehabilitation Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 VISHEE Neurorehabilitation Product Portfolio
- 6.1.5 VISHEE Recent Developments
- 6.2 Beijing Bo'ai Hospital
- 6.2.1 Beijing Bo'ai Hospital Company Information
- 6.2.2 Beijing Bo'ai Hospital Business Overview
- 6.2.3 Beijing Bo'ai Hospital Neurorehabilitation Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Beijing Bo'ai Hospital Neurorehabilitation Product Portfolio
- 6.2.5 Beijing Bo'ai Hospital Recent Developments
- 6.3 Beijing Rehabilitation Hospital of Capital Medical University
- 6.3.1 Beijing Rehabilitation Hospital of Capital Medical University Company Information
- 6.3.2 Beijing Rehabilitation Hospital of Capital Medical University Business Overview
- 6.3.3 Beijing Rehabilitation Hospital of Capital Medical University Neurorehabilitation Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Beijing Rehabilitation Hospital of Capital Medical University Neurorehabilitation Product Portfolio
- 6.3.5 Beijing Rehabilitation Hospital of Capital Medical University Recent Developments
- 6.4 NCC
- 6.4.1 NCC Company Information
- 6.4.2 NCC Business Overview
- 6.4.3 NCC Neurorehabilitation Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 NCC Neurorehabilitation Product Portfolio
- 6.4.5 NCC Recent Developments
- 6.5 CHIEFTAIN
- 6.5.1 CHIEFTAIN Company Information
- 6.5.2 CHIEFTAIN Business Overview
- 6.5.3 CHIEFTAIN Neurorehabilitation Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 CHIEFTAIN Neurorehabilitation Product Portfolio
- 6.5.5 CHIEFTAIN Recent Developments
- 6.6 Tongji Hospital
- 6.6.1 Tongji Hospital Company Information
- 6.6.2 Tongji Hospital Business Overview
- 6.6.3 Tongji Hospital Neurorehabilitation Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Tongji Hospital Neurorehabilitation Product Portfolio
- 6.6.5 Tongji Hospital Recent Developments
- 6.7 Haobro Medical Device
- 6.7.1 Haobro Medical Device Company Information
- 6.7.2 Haobro Medical Device Business Overview
- 6.7.3 Haobro Medical Device Neurorehabilitation Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Haobro Medical Device Neurorehabilitation Product Portfolio
- 6.7.5 Haobro Medical Device Recent Developments
- 6.8 DIH
- 6.8.1 DIH Company Information
- 6.8.2 DIH Business Overview
- 6.8.3 DIH Neurorehabilitation Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 DIH Neurorehabilitation Product Portfolio
- 6.8.5 DIH Recent Developments
- 6.9 Sun Java
- 6.9.1 Sun Java Company Information
- 6.9.2 Sun Java Business Overview
- 6.9.3 Sun Java Neurorehabilitation Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Sun Java Neurorehabilitation Product Portfolio
- 6.9.5 Sun Java Recent Developments
- 6.10 Aoyang Health
- 6.10.1 Aoyang Health Company Information
- 6.10.2 Aoyang Health Business Overview
- 6.10.3 Aoyang Health Neurorehabilitation Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Aoyang Health Neurorehabilitation Product Portfolio
- 6.10.5 Aoyang Health Recent Developments
- 6.11 PKUCare Rehabilitation Hospital
- 6.11.1 PKUCare Rehabilitation Hospital Company Information
- 6.11.2 PKUCare Rehabilitation Hospital Business Overview
- 6.11.3 PKUCare Rehabilitation Hospital Neurorehabilitation Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 PKUCare Rehabilitation Hospital Neurorehabilitation Product Portfolio
- 6.11.5 PKUCare Rehabilitation Hospital Recent Developments
- 6.12 Beijing Puhua International Hospital
- 6.12.1 Beijing Puhua International Hospital Company Information
- 6.12.2 Beijing Puhua International Hospital Business Overview
- 6.12.3 Beijing Puhua International Hospital Neurorehabilitation Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Beijing Puhua International Hospital Neurorehabilitation Product Portfolio
- 6.12.5 Beijing Puhua International Hospital Recent Developments
- 6.13 Xiangyu Medical
- 6.13.1 Xiangyu Medical Company Information
- 6.13.2 Xiangyu Medical Business Overview
- 6.13.3 Xiangyu Medical Neurorehabilitation Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Xiangyu Medical Neurorehabilitation Product Portfolio
- 6.13.5 Xiangyu Medical Recent Developments
- 6.14 Beijing United Family Rehabilitation Hospital
- 6.14.1 Beijing United Family Rehabilitation Hospital Company Information
- 6.14.2 Beijing United Family Rehabilitation Hospital Business Overview
- 6.14.3 Beijing United Family Rehabilitation Hospital Neurorehabilitation Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Beijing United Family Rehabilitation Hospital Neurorehabilitation Product Portfolio
- 6.14.5 Beijing United Family Rehabilitation Hospital Recent Developments
7 North America
- 7.1 North America Neurorehabilitation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Neurorehabilitation Market Size by Country (2021-2026)
- 7.3 North America Neurorehabilitation Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Neurorehabilitation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Neurorehabilitation Market Size by Country (2021-2026)
- 8.3 Europe Neurorehabilitation Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Neurorehabilitation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Neurorehabilitation Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Neurorehabilitation Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Neurorehabilitation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Neurorehabilitation Market Size by Country (2021-2026)
- 10.3 South America Neurorehabilitation Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Neurorehabilitation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Neurorehabilitation Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Neurorehabilitation Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst